Home/Filings/4/0001179110-21-004605
4//SEC Filing

KANEKO YASUNORI 4

Accession 0001179110-21-004605

CIK 0001724521other

Filed

Apr 25, 8:00 PM ET

Accepted

Apr 26, 4:16 PM ET

Size

7.1 KB

Accession

0001179110-21-004605

Insider Transaction Report

Form 4
Period: 2021-04-23
Transactions
  • Purchase

    Common Stock

    2021-04-23$31.37/sh+4,133$129,6527,133 total
Holdings
  • Common Stock

    (indirect: By Trust)
    131,948
  • Common Stock

    (indirect: By LLC)
    505,050
  • Common Stock

    (indirect: By LLC)
    252,524
Footnotes (3)
  • [F1]Shares purchased in a private transaction from Dr. William Grossman, Arcus's Chief Medical Officer.
  • [F2]Thirty-five thousand (35,000) shares previously held directly by the reporting person were transferred to reporting person's trust.
  • [F3]The reporting person's direct ownership includes three thousand (3,000) shares that are Restricted Stock Units that will not vest until June 3, 2021.

Issuer

Arcus Biosciences, Inc.

CIK 0001724521

Entity typeother

Related Parties

1
  • filerCIK 0001277503

Filing Metadata

Form type
4
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 4:16 PM ET
Size
7.1 KB